Recent study showed that preclinical altered blood-based ACTB methylation had a significant correlation with stroke, which suggested that it might be a potential regulatory indicator for early detection and even prevention of stroke (Liu et al., 2021). This evidence concerns the gene ACTB and stroke disorder.